PROJECT INFORMATION
GOLD Project ID
Gp0550436  
Project Name
Lysinibacillus macroides FDAARGOS_925  
Other Names
  
Legacy GOLD ID
  
NCBI BioProject Name
  
NCBI BioProject Accession PRJNA231221
NCBI Locus Tag
I6G82  
NCBI BioSample Accession SAMN13450455
PI
Added By JGI automated process on 2021-03-12
Last Modified By JGI automated process on 2021-03-19
Project Comments
  
Project Status
Complete and Published  
Project Relevance Medical
Sequencing Center U.S. Food and Drug Administration (FDA) (USA)
Institute for Genome Sciences, University of Maryland School of Medicine (USA)
Collaborating Institute
  
Funding Agency
  
Project Description
Lysinibacillus macroides FDAARGOS_925 genome sequencing  
Is JGI Project
No  
Project Information Visibility Public
PROJECT TYPE
Specimen Organism
Nucleic Acid DNA
Sequencing Strategy
Whole Genome Sequencing  
EXTERNAL PROJECT LINKS
JGI Data Utilization Status
  
JGI Award DOI
Genome Publications
  
Other Publications
  
Ignored Publications
  
Unassigned Publications Nature communications 10(1):3313 FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science.

SRA Experiment
 
SRA Experiment Id SRX8577047  (Link to NCBI )
Exp Library Strategy WGS
Library Source GENOMIC
Library Selection RANDOM
Library Name PL100105039-1
Library Layout SINGLE
Library Instrument PAC_BIO_RS
 
SRA Experiment Id SRX8577046  (Link to NCBI )
Exp Library Strategy WGS
Library Source GENOMIC
Library Selection RANDOM
Library Name IL100105793
Library Layout PAIRED
Library Instrument ILLUMINA_HI_SEQ_4000
 
SRA Experiment Id SRX8577048  (Link to NCBI )
Exp Library Strategy WGS
Library Source GENOMIC
Library Selection RANDOM
Library Name PL100105039-1
Library Layout SINGLE
Library Instrument PAC_BIO_RS
PROJECT COMPOSITION
Study Genome sequencing as part of FDA-ARGOS: dAtabase for Regulatory Grade micrObial Sequences project
Organism Lysinibacillus macroides FDAARGOS_925
Analysis Projects Lysinibacillus macroides FDAARGOS_925
Number of Analysis Projects (AP) 1
Number of Derived Analyis Projects (DAP)
0  
SEQUENCING INFORMATION
Sequencing Status Complete
Sequencing Quality (MIGS-31) Level 6: Finished
Finishing Goal
Contamination Screening Input
  
DNA Amplification Method
  
Single Cell Lysis Protocol
  
Single Cell Lysis Approach
  
Sequencing Comments
  
DNA Amplification Kit
  
Sequencing Technology (MIGS-29) Illumina
Pacbio
Library Method (MIGS-28)
  
Library Layout
  
Library Screening Method
  
Number Of Reads
  
Read Size
  
Vector
  
GC Percent
  
Chromosome Count
  
Plasmid Count
  
ORGANISM NAME
GOLD Organism ID Go0575707
Organism Name
Lysinibacillus macroides FDAARGOS_925  
Other names (alias, synonyms, short names, common names)
  
Organism Domain
BACTERIAL  
Phylogeny
FIRMICUTES  
Genus
Lysinibacillus  
Genus Synonyms
  
Species
Lysinibacillus macroides  
Subspecies
  
Species Synonyms
  
Strain
FDAARGOS_925  
Strain Synonyms
  
Serovar/Cultivar
  
Culture Collection ID
FDA FDAARGOS_925  
Type Strain
  
Exemplar DOI
  
Exemplar Name
  
Taxon DOI
  
Biosafety Level
  
Organism Comments
  
Cultured
Yes  
Culture Type
Isolate  
Organism Type
Natural  
Uncultured Type
  
Commercial Strain
  
Commercial Strain Comments
  
ORGANISM TAXONOMY
NCBI Taxonomy ID 33935
NCBI Superkingdom
Bacteria  
NCBI Kingdom
  
NCBI Phylum
Firmicutes  
NCBI Class
Bacilli  
NCBI Order
Bacillales  
NCBI Family
Bacillaceae  
NCBI Genus
Lysinibacillus  
NCBI Species
Lysinibacillus macroides  
ISOLATION CLASSIFICATION
Ecosystem
  
Ecosystem Category
  
Ecosystem Type
  
Ecosystem Subtype
  
Specific Ecosystem
  
ORGANISM EXTERNAL REFERENCES
Strain Info ID
Genbank 16S ID
GENERAL PROPERTIES
Oxygen Requirement
  
Cell Shape
  
Motility
  
Sporulation
  
Temperature Range
  
Salinity
  
pH
  
Cell Diameter
  
Cell Length
  
Color
  
Gram Staining
  
Biotic Relationships
  
Symbiotic Physical Interaction
  
Symbiotic Relationship
  
Symbiont Name
  
Symbiont Taxon ID
  
Cell Arrangements
  
Diseases
  
Known Habitats
  
Metabolisms
  
Phenotypes
  
Energy Sources
  

 

 

  You are going to add the following user to your project, biosample and study.

 

Contact Name/Email:

Do you want to continue?

 

 

  You are going to remove permissions for the following user to your project, biosample and study.

 

Contact Name/Email:

Do you want to continue?

 

 

  Changing the SP visibility will also change visibility on the following items:

 

Do you want to continue with this visibility change?

 

 

  Checking that this Sequencing Project can be made private:

 

Do you want to continue with this visibility change?

 

 

 

 

 

  Changing the SP Sequencing Strategy will also effect these items:

 

Do you want to continue with this Sequencing Strategy change?